GDM-associated insulin deficiency hinders the dissociation of SERT from ERp44 and down-regulates placental 5-HT uptake

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 52, 2014, Pages E5697-E5705

  Li, Yicong ^a   Hadden, Coedy ^a   Singh, Preeti ^a   Mercado, Charles P ^a   Murphy, Pamela ^a   Dajani, Nafisa K ^a   Lowery, Curtis L ^a   Roberts, Drucilla J ^b   Maroteaux, Luc ^c   Kilic, Fusun ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c INSTITUT DU FER À MOULIN   (France)

Author keywords

ERp44; Gestational diabetes mellitus; Insulin; Serotonin; Serotonin transporter

Indexed keywords

AMINO ACID; CHAPERONE; CYTOPLASM PROTEIN; ERP44 PROTEIN; GLUCOSE; HUMAN INSULIN; INSULIN; INSULIN RECEPTOR; PLACENTAL PEPTIDE HORMONE; SEROTONIN; SEROTONIN TRANSPORTER; TUNICAMYCIN; UNCLASSIFIED DRUG; ERP44 PROTEIN, HUMAN; MEMBRANE PROTEIN; SLC6A4 PROTEIN, HUMAN;

ADULT; ARTICLE; BIOTINYLATION; CELL MIGRATION; CONTROLLED STUDY; DISSOCIATION; DISULFIDE BOND; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN DEFICIENCY; INSULIN TREATMENT; MOLECULAR WEIGHT; PLACENTA; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; SEROTONIN BLOOD LEVEL; SEROTONIN UPTAKE; SIGNAL TRANSDUCTION; SURFACE PROPERTY; TROPHOBLAST; ADOLESCENT; BIOSYNTHESIS; CLINICAL TRIAL; GLYCOSYLATION; METABOLISM; PATHOLOGY; PREGNANCY;

ADOLESCENT; ADULT; DIABETES, GESTATIONAL; DOWN-REGULATION; FEMALE; GLYCOSYLATION; HUMANS; INSULIN; MEMBRANE PROTEINS; MOLECULAR CHAPERONES; PREGNANCY; PROTEIN PROCESSING, POST-TRANSLATIONAL; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SIGNAL TRANSDUCTION; TROPHOBLASTS;

EID: 84924587656     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1416675112     Document Type: Article

References (77)

1. Centers for Disease Control and Prevention (2011) National Diabetes Fact Sheet, www.cdc.gov/diabetes/pubs/estimates11.htm.
2. Metzger BE, et al. (2007) Summary and recommendations of the Fifth International Workshop- Conference on Gestational Diabetes Mellitus. Diabetes Care 30(Suppl 2):S251-S260.
3. Buchanan TA, Xiang A, Kjos SL, Watanabe R (2007) What is gestational diabetes? Diabetes Care 30(Suppl 2):S105-S111.
4. Catalano PM, Kirwan JP, Haugel-de Mouzon S, King J (2003) Gestational diabetes and insulin resistance: Role in short- and long-term implications for mother and fetus. J Nutr 133(5, Suppl 2):1674S-1683S.
5. Kim C, Newton KM, Knopp RH (2002) Gestational diabetes and the incidence of type 2 diabetes: A systematic review. Diabetes Care 25(10):1862-1868.
6. Yamashita H, Shao J, Friedman JE (2000) Physiologic and molecular alterations in carbohydrate metabolism during pregnancy and gestational diabetes mellitus. Clin Obstet Gynecol 43(1):87-98.
7. Catalano PM, et al. (1993) Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. Am J Physiol 264(1 Pt 1):E60-E67.
8. Vrachnis N, et al. (2012) Impact of maternal diabetes on epigenetic modifications leading to diseases in the offspring. Exp Diabetes Res 2012:538474.
9. Colomiere M, Permezel M, Riley C, Desoye G, Lappas M (2009) Defective insulin signaling in placenta from pregnancies complicated by gestational diabetes mellitus. Eur J Endocrinol 160(4):567-578.
10. Bentley-Lewis R, Dawson DL, Wenger JB, Thadhani RI, Roberts DJ (2014) Placental histomorphometry in gestational diabetes mellitus: The relationship between subsequent type 2 diabetes mellitus and race/ethnicity. Am J Clin Pathol 141(4):587-592.
11. Balsells M, García-Patterson A, Gich I, Corcoy R (2012) Major congenital malformations in women with gestational diabetes mellitus: A systematic review and meta-analysis. Diabetes Metab Res Rev 28(3):252-257.
12. Liu KP, Tamir H, Hsiung S, Adlersberg M, Gershon MD (1987) Prenatal development of serotonin binding protein in relation to other transmitter-related characteristics of central serotonergic neurons. Brain Res 429(1):31-41.
13. Lauder JM, Tamir H, Sadler TW (1988) Serotonin and morphogenesis. I. Sites of serotonin uptake and -binding protein immunoreactivity in the midgestation mouse embryo. Development 102(4):709-720.
14. Lauder JM (1993) Neurotransmitters as growth regulatory signals: Role of receptors and second messengers. Trends Neurosci 16(6):233-240.
15. Côté F, et al. (2003) Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function. Proc Natl Acad Sci USA 100(23):13525-13530.
16. Rubenstein JLR (1998) Development of serotonergic neurons and their projections. Biol Psychiatry 44(3):145-150.
17. Bonnin A, et al. (2011) A transient placental source of serotonin for the fetal forebrain. Nature 472(7343):347-350.
18. Kim H, et al. (2010) Serotonin regulates pancreatic beta cell mass during pregnancy. Nat Med 16(7):804-808.
19. Paulmann N, et al. (2009) Intracellular serotonin modulates insulin secretion from pancreatic beta-cells by protein serotonylation. PLoS Biol 7(10):e1000229.
20. Barradas MA, Gill DS, Fonseca VA, Mikhailidis DP, Dandona P (1988) Intraplatelet serotonin in patients with diabetes mellitus and peripheral vascular disease. Eur J Clin Invest 18(4):399-404.
21. Côté F, et al. (2007) Maternal serotonin is crucial for murine embryonic development. Proc Natl Acad Sci USA 104(1):329-334.
22. Taylor SE, et al. (2006) Early family environment, current adversity, the serotonin transporter promoter polymorphism, and depressive symptomatology. Biol Psychiatry 60(7):671-676.
23. FDA Drug Safety Communication (2011) Selective serotonin reuptake inhibitor (SSRI) antidepressant use during pregnancy and reports of a rare heart and lung condition in newborn babies. Available at www.fda.gov/Drugs/DrugSafety/ucm283375.htm.
24. Rapport MM, Green AA, Page IH (1948) Serum vasoconstrictor, serotonin; isolation and characterization. J Biol Chem 176(3):1243-1251.
25. Ganapathy V, Leibach FH (1994) Human placenta: A direct target for cocaine action. Placenta 15(8):785-795.
26. Filshie GM, et al. (1992) Urinary 5-hydroxyindole acetate concentration in pregnancy induced hypertension. BMJ 304(6836):1223.
27. Redline RW, et al.; Society for Pediatric Pathology, Perinatal Section, Maternal Vascular Perfusion Nosology Committee (2004) Maternal vascular underperfusion: Nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 7(3):237-249.
28. Middelkoop CM, Dekker GA, Kraayenbrink AA, Popp-Snijders C (1993) Platelet-poor plasma serotonin in normal and preeclamptic pregnancy. Clin Chem 39(8):1675-1678.
29. Red-Horse K, et al. (2004) Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. J Clin Invest 114(6):744-754.
30. Anelli T, Sitia R (2008) Protein quality control in the early secretory pathway. EMBO J 27(2):315-327.
31. Anelli T, et al. (2003) Thiol-mediated protein retention in the endoplasmic reticulum: The role of ERp44. EMBO J 22(19):5015-5022.
32. Anelli T, et al. (2007) Sequential steps and checkpoints in the early exocytic compartment during secretory IgM biogenesis. EMBO J 26(19):4177-4188.
33. Gielen W, Viehöfer B (1974) The effect of neuraminidase on the 5-hydroxytryptamine uptake of human platelets. Experientia 30(10):1177-1178.
34. Dette GA, Wesemann W (1979) The role of sialic acid in 5-HT binding to synaptic membranes. Experientia 35(9):1152-1153.
35. Michal F, et al. (1972) Effect of 5-hydroxytryptamine on the potassium ion exchange of human platelets enriched in sialic acid. Biochem J 129:977-978.
36. Launay JM, et al. (1992) One-step purification of the serotonin transporter located at the human platelet plasma membrane. J Biol Chem 267(16):11344-11351.
37. Ozaslan D, et al. (2003) Glycosyl modification facilitates homo- and hetero-oligomerization of the serotonin transporter. A specific role for sialic acid residues. J Biol Chem 278(45):43991-44000.
38. Chen JG, Liu-Chen S, Rudnick G (1997) External cysteine residues in the serotonin transporter. Biochemistry 36(6):1479-1486.
39. Freyaldenhoven S, et al. (2012) The role of ERp44 in maturation of serotonin transporter protein. J Biol Chem 287(21):17801-17811.
40. rd (1986) Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology 118(4):1567-1582.
41. Manoussaka MS, Jackson DJ, Lock RJ, Sooranna SR, Kumpel BM (2005) Flow cytometric characterisation of cells of differing densities isolated from human term placentae and enrichment of villous trophoblast cells. Placenta 26(4):308-318.
42. Clover LM, Coghill E, Redman CW, Sargent IL (2000) A three-colour flow cytometry technique for measuring trophoblast intracellular antigens: The relative expression of TAP1 in human cytotrophoblast and decidual cells. Placenta 21(8):743-753.
43. Maldonado-Estrada J, Menu E, Roques P, Barré-Sinoussi F, Chaouat G (2004) Evaluation of Cytokeratin 7 as an accurate intracellular marker with which to assess the purity of human placental villous trophoblast cells by flow cytometry. J Immunol Methods 286(1-2):21-34.
44. Bulmer JN, Billington WD, Johnson PM (1984) Immunohistologic identification of trophoblast populations in early human pregnancy with the use of monoclonal antibodies. Am J Obstet Gynecol 148(1):19-26.
45. Unal R, et al. (2007) At diabetes-like concentration, glucose down-regulates the placental serotonin transport system by abolishing its homo-oligomerization. J Neurochem 101:937-948.
46. Elbein AD (1991) Glycosidase inhibitors: Inhibitors of N-linked oligosaccharide processing. FASEB J 5(15):3055-3063.
47. Luo J, Field SJ, Lee JY, Engelman JA, Cantley LC (2005) The p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complex. J Cell Biol 170(3):455-464.
48. Avruch J (1998) Insulin signal transduction through protein kinase cascades. Mol Cell Biochem 182(1-2):31-48.
49. Barbour LA, et al. (2011) Chronically increased S6K1 and IRS1 serine phosphorylation are associated with skeletal muscle insulin resistance in GDM women with impaired glucose tolerance postpartum. J Clinical Endocrinology & Metabolism 96:1431-1441.
50. Boileau P, Caüzac M, Pereira MA, Girard J, Hauguel-De Mouzon S (2001) Dissociation between insulin-mediated signaling pathways and biological effects in placental cells: Role of protein kinase B and MAPK phosphorylation. Endocrinology 142(9):3974-3979.
51. Wang ZV, et al. (2007) Secretion of the adipocyte-specific secretory protein adiponectin critically depends on thiol-mediated protein retention. Mol Cell Biol 27(10):3716-3731.
52. Seale AP, de Jesus LA, Park MC, Kim YS (2006) Vanadium and insulin increase adiponectin production in 3T3-L1 adipocytes. Pharmacol Res 54(1):30-38.
53. Tamir H, Gershon MD (1990) Serotonin-storing secretory vesicles. Ann N Y Acad Sci 600:53-66, discussion 67.
54. Balkovetz DF, Tiruppathi C, Leibach FH, Mahesh VB, Ganapathy V (1989) Evidence for an imipramine-sensitive serotonin transporter in human placental brush-border membranes. J Biol Chem 264(4):2195-2198.
55. Padbury JF, et al. (1997) Placental biogenic amine transporters: Cloning and expression. Brain Res Mol Brain Res 45(1):163-168.
56. Ramamoorthy S, et al. (1993) Regulation of the human serotonin transporter. Cholera toxin-induced stimulation of serotonin uptake in human placental choriocarcinoma cells is accompanied by increased serotonin transporter mRNA levels and serotonin transporter-specific ligand binding. J Biol Chem 268(29):21626-21631.
57. Tamir H, Kupsky WJ, Huang YL, Gershon MD (1983) Serotonin-binding glycoprotein of rat platelets. J Cell Sci 62:439-458.
58. Lesch KP, Wolozin BL, Murphy DL, Reiderer P (1993) Primary structure of the human platelet serotonin uptake site: Identity with the brain serotonin transporter. J Neurochem 60(6):2319-2322.
59. Lesch KP, Wolozin BL, Estler HC, Murphy DL, Riederer P (1993) Isolation of a cDNA encoding the human brain serotonin transporter. J Neural Transm 91(1):67-72.
60. Bhat GB and Block ER. (1990). Hypoxia directly increases serotonin transport by porcine pulmonary artery endothelial cell plasma membrane vesicles. Am J Respir Cell Mol Biol. 4:363-7.
61. Wade PR, et al. (1996) Localization and function of a 5-HT transporter in crypt epithelia of the gastrointestinal tract. J Neurosci 16(7):2352-2364.
62. Chen X, Margolis KJ, Gershon MD, Schwartz GJ, Sze JY (2012) Reduced serotonin reuptake transporter (SERT) function causes insulin resistance and hepatic steatosis independent of food intake. PLoS ONE 7(3):e32511.
63. Bradley CC, Blakely RD (1997) Alternative splicing of the human serotonin transporter gene. J Neurochem 69(4):1356-1367.
64. Noorlander CW, et al. (2008) Modulation of serotonin transporter function during fetal development causes dilated heart cardiomyopathy and lifelong behavioral abnormalities. PLoS ONE 3(7):e2782.
65. Mekontso-Dessap A, et al. (2006) Deficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in mice. Circulation 113(1):81-89.
66. Viau M, Lafond J, Vaillancourt C (2009) Expression of placental serotonin transporter and 5-HT 2A receptor in normal and gestational diabetes mellitus pregnancies. Reprod Biomed Online 19(2):207-215.
67. Gall V, et al. (2011) Platelet serotonin concentration at term pregnancy and after birth: Physiologic values for Croatian population. Coll Antropol 35(3):715-718.
68. Kilic F, Rudnick G (2000) Oligomerization of serotonin transporter and its functional consequences. Proc Natl Acad Sci USA 97(7):3106-3111.
69. Nguyen TT and Amara SG. (1996). N-linked oligosaccharides are required for cell surface expression of the norepinephrine transporter but do not influence substrate or inhibitor recognition. J. Neurochem. 67: 645-655.28.
70. Chen R, et al. (2007) Direct evidence that two cysteines in the dopamine transporter form a disulfide bond. Mol Cell Biochem 298(1-2):41-48.
71. Torres GE, et al. (2003) Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter. J Biol Chem 278(4):2731-2739.
72. Hurtley SM, Helenius A (1989) Protein oligomerization in the endoplasmic reticulum. Annu Rev Cell Biol 5:277-307.
73. Braakman I, Hoover-Litty H, Wagner KR, Helenius A (1991) Folding of influenza hemagglutinin in the endoplasmic reticulum. J Cell Biol 114(3):401-411.
74. Klausner RD (1989) Architectural editing: Determining the fate of newly synthesized membrane proteins. New Biol 1(1):3-8.
75. Mercado CP, et al. (2013) A serotonin-induced N-glycan switch regulates platelet aggregation. Sci Rep 3:2795.
76. Ziu E, et al. (2012) Down-regulation of the serotonin transporter in hyperreactive platelets counteracts the pro-thrombotic effect of serotonin. J Mol Cell Cardiol 52(5):1112-1121.
77. Brenner B, et al. (2007) Plasma serotonin levels and the platelet serotonin transporter. J Neurochem 102(1):206-215.